No abstract

Ehretia acuminata, commonly known as “Puna” in Pakistan, is from the Boraginaceae family and is used in ecological, medicinal, and agricultural sectors. The current study was conducted to assess the pharmacognostic potency of bark extracts from E. acuminata. The crude distilled water, ethanol, and chloroform extracts signified a concentration-dependent increase in intestinal mobility of the experimented animal, and the plant delivered methodical proof for its pharmacological usage as an antispasmodic drug. The bark distilled water, bark ethanol, and bark chloroform extracts revealed (11±1, 9±1, and 11±1) antispasmodic potential at (300 mg/kg). The distilled water, ethanol, and chloroform extracts also showed analgesic potential in the present study and the results were concentration dependent. The bark distilled water, bark ethanol, and bark chloroform extracts revealed the (10±1,16±1, and 11±1) analgesic potential at (300 mg/kg). The distilled water, ethanol, and chloroform extracts also showed the muscle relaxant potential in this study and the results were concentration dependent. The Bark distilled water, Bark ethanol, and Bark chloroform extracts revealed the (6±1, 5±1, and 5±1) at (300 mg/kg). While the distilled water, ethanol and chloroform extracts did not show acute toxic effects against the tested animal mice. In this study, bark extracts of E. acuminata showed pharmacological potency in experimental animals. The plant delivered scientific proof for its pharmacological usage as an antispasmodic, acutely toxic, muscle relaxant, as well as an analgesic drug.

Background and Aim: Several factors contribute to the poor outcomes of peripheral arterial disease (PAD). The current study examined the results of peripheral transluminal angioplasty (PTA) in diabetics and non-diabetics with peripheral arterial disease (PAD). Patients and Methods: This cross-sectional study was carried out on 136 peripheral arteries disease patients including 84 non-diabetic and 52 diabetics in the department of Cardiology, Hayatabad Medical Complex, Peshawar during the period from January 2022 to June 2022. This study included patients with PADs who had PTAs performed on their femoral, iliac, infrapopliteal, and popliteal arteries. Study protocol was approved by the research and ethical committee. Patient’s demographic details and medical history were recorded. SPSS version 26 was used for data analysis. Results: The overall mean age was 64.6 ± 10.51 years. Diabetic patients were compared with non-diabetic patients in terms of age (63.8±11.2 versus 65.4± 9.82 years), smoking history (80.7% vs. 46.4%), hypercholesterolemia (25.4% versus 31.9%), and ischemic heart disease (40.6% versus 36.5%). The frequency of hypertensive patients was higher 64.8% in diabetic patients against 40.6% in non-diabetic patients. In terms of arterial segment below the knee and profunda femoris, arterial disease had higher severity in diabetic patients. Diabetic patients were more susceptible to amputation (43.2% vs. 12%, OR=4.8, P=0.001) and had higher mortality (48.9% versus 23.8%). Conclusion: The present study found that higher prevalence of limb ischemia, amputation, and higher rates of restenosis following peripheral transluminal angioplasty was found in diabetic patients compared to non-diabetic patients. Diabetic patients had poor prognosis and worse arterial disease than non-diabetic patients. Keywords: Diabetic patients, Angiographic characteristics, Peripheral arteries disease.